Download Files:
Bizine
SKU
HY-121095-10mg
Category Reference compound
Tags Cancer; Neurological Disease, Epigenetics, Histone Demethylase
$276 – $442
Products Details
Product Description
– Bizine, a Phenelzine analogue, is a potent and selective LSD1 inhibitor, with a b>Ki of 59 nM. Bizine can modulate bulk histone methylation in cancer cells. Bizine shows neuroprotective effects[1].
Web ID
– HY-121095
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C18H23N3O
References
– [1]Prusevich P, et, al. A selective phenelzine analogue inhibitor of histone demethylase LSD1. ACS Chem Biol. 2014 Jun 20;9(6):1284-93.
CAS Number
– 1591932-50-1
Molecular Weight
– 297.39
SMILES
– NNCCC1=CC=C(NC(CCCC2=CC=CC=C2)=O)C=C1
Clinical Information
– No Development Reported
Research Area
– Cancer; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Histone Demethylase
Isoform
– KDM1/LSD1
Pathway
– Epigenetics
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.